Effect of Particle Size of Zinc Oxides on Cytotoxicity and Cell Permeability ? in Caco-2 Cells Research Note ?

Journal of Food Science and Nutrition

Volumn 16, Issue 2, 2011, Pages 174-178

  Chang, Hyun Joo ^a   Choi, Sung Wook ^a   Ko, Sanghoon ^b   Chun, Hyang Sook ^a  

^a Korea Food Research Institute   (South Korea)

^b Sejong University   (South Korea)

Author keywords

Caco 2; Cell permeability; Cytotoxicity; Particle size effect; Zinc oxide

Indexed keywords

EID: 84866549705     PISSN: 1226332X     EISSN: None     Source Type: Journal    
DOI: 10.3746/jfn.2011.16.2.174     Document Type: Article

References (29)

1. Tarver T. 2006. Food nanotechnology. Food Technol 60: 22-26.
2. Park B. 2009. Nanotechnology for food safety. Cereal Foods World 54: 158-162.
3. Bouwmeester H, Dekkers S, Noordam MY, Hagens WI, Bulder AS, de Heer C, ten Voorde SE, Wijnhoven SW, Marvin HJ, Sips AJ. 2009. Review of health safety aspects of nanotechnologies in food production. Regul Toxicol Pharmacol 53: 52-62.
4. Oberdörster G, Oberdörster E, Oberdörster J. 2005. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113: 823-839.
5. Hoet P, Bruske-Hohlfeld I, Salata O. 2004. Nanoparticlesknown and unknown health risks. J Nanobiotechnol 2: 12-26.
6. Powers KW, Palazuelos M, Moudgil BM, Roberts SM. 2007. Characterization of the size, shape, and state of dispersion of nanoparticles for toxicological studies. Nanotoxicology 1: 42-51.
7. Stefanidou M, Maravelias C, Dona A, Spiliopolou C. 2006. Zinc: a multipurpose trace element. Arch Toxicol 80: 1-9.
8. Rosado JL. 2003. Zinc and copper: proposed fortification levels and recommended zinc compounds. J Nutr 133: 2985S-2989S.
9. Friends of the Earth, Australia, Europe and U.S.A. 2008. Out of the laboratory and on to our plates, nanotechnology in food & agriculture. A report. p 1-63.
10. Shah P, Jogani V, Bagchi T, Misra A. 2006. Role of Caco-2 cell monolayers in prediction of intestinal drug absorption. Biotech Prog 22: 186-198.
11. Dobrovolskaia M. 2007. Immunological properties of engineered nanomaterials. Nature Nanotechnol 2: 469-478.
12. Khan R, Kaushik A, Solanki RR, Ansari AA, Pandey MM, Malhotra BD. 2008. Zinc oxide nanoparticles-chitosan composite film for cholesterol biosensor. Anal Chim Acta 616: 207-213.
13. Opanasopit P, Aumklad P, Kowapradit J, Ngawhiranpat T, Apirakaramwong A, Rojanarata T. 2007. Effect of salt form and molecular weight of chitosan on in vitro permeability enhancement in intestinal epithelial cells (Caco-2). Pharmaceut Develop Technol 12: 447-455.
14. Rekha MR, Sharma CP. 2009. Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption. J Control Release 135: 144-151.
15. Chen FZ, Zhang R, Yuan F, Qin X, Wang M, Huang Y. 2008. In vitro and in vivo study of N-trimethyl chitosan nanoparticles for oral protein delivery. Int J Pharm 49: 226-233.
16. Lin YH, Chung CK, Chen CT, Liang HF, Chen SC, Sung HW. 2005. Preparation of nanoparticles composed of chitosan /poly-γ-glutamic acid and evaluation of their permeability through Caco-2 cells. Biomacromolecules 6: 1104-1112.
17. Markowska M, Oberle R, Juzwin S, Hsu CP, Gryszkiewicz M, Streeter AJ. 2001. Optimizing Caco-2 cell monolayers to increase throughput in drug intestinal absorption analysis. J Pharmacol Toxicol Methods 46: 51-55.
18. McCall KA, Fierke CA. 2000. Colorimetric and fluorimetric assays to quantitate micromolar concentrations of transition metals. Anal Biochem 284: 307-315.
19. Tantra R, Tompkins J, Quincey P. 2010. Characterisation of the de-agglomeration effects of bovine serum albumin on nanoparticles in aqueous suspension. Colloids Surf B: Biointerfaces 75: 275-281.
20. Kato H, Suzuki M, Fujita K, Horie M, Endoh S, Yoshida Y, Iwahashi H, Takahashi K, Nakamura A, Kinugasa S. 2009. Reliable size determination of nanoparticles using dynamic light scattering method for in vitro toxicology assessment. Toxicol in Vitro 23: 927-934.
21. Zhang Y, Chen Y, Westerhoff P, Hristovski K, Crittenden JC. 2008. Stability of commercial metal oxide nanoparticles in water. Water Res 42: 2204-2212.
22. Murdock RC, Braydich-Stolle L, Schrand AM, Schlager JJ, Hussain SM. 2008. Characterization of nanomaterial dispersion in solution prior to in vitro exposure using dynamic light scattering technique. Toxicol Sci 101: 239-253.
23. Yang H, Liu C, Yang D, Zhang H, Xi Z. 2008. Comparative study of cytotoxicity, oxidative stress and genotoxicity induced by four typical nanomaterials: the role of particle size, shape and composition. J Appl Toxicol 29: 69-78.
24. Heng BC, Zhao X, Xiong S, Ng KW, Boey FYC, Loo JSC. 2010. Toxicity of zinc oxide (ZnO) nanoparticles on human bronchial epithelial cells (BEAS-2B) is accentuated by oxidative stress. Food Chem Toxicol 48: 1762-1766.
25. Hackenberg S, Scherzed A, Technau A, Kessler M, Froelich K, Ginzkey C, Koehler C, Burghartz M, Hagen R, Kleinsasser N. 2011. Cytotoxic, genotoxic and pro-inflammatory effects of zinc oxide nanoparticles in human nasal mucosa cells in vitro. Toxicol in Vitro 25: 657-663.
26. Nair S, Sasidharan A, Rani VVD, Menon D, Nair S, Manzoor K, Raina S. 2009. Role of size scale of ZnO nanoparticles and microparticles on toxicity toward bacteria and osteoblast cancer cells. J Mater Sci Mater Med 20: S235-241.
27. Colon G, Ward BC, Webster TJ. 2006. Increased osteoblast and decreased Staphylococcus epidermidis functions on nanophase ZnO and TiO2. J Biomed Mater Res 78A: 595-604.
28. Yamashita S, Furubayashi T, Kataoka M, Sakane T, Sezaki H, Tokuda H. 2000. Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells. Eur J Pharm Sci 10: 195-204.
29. Jia L, Wong H, Cerna C, Weitman SD. 2002. Effect of nanonization on absorption of 301029: ex vivo and in vivo pharmacokinetic correlations determined by liquid chromatography/mass spectrometry. Pharm Res 19: 1091-1096.